Matthew Blischak
Director Ejecutivo en FINCH THERAPEUTICS GROUP, INC. .
Fortuna: - $ al 31/05/2024
Cargos activos de Matthew Blischak
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Director Ejecutivo | 16/05/2023 | - |
| Presidente | 16/05/2023 | - | |
| Secretario Corporativo | 16/05/2023 | - |
Historial de carrera de Matthew Blischak
Antiguos cargos conocidos de Matthew Blischak.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/05/2018 | 01/04/2023 |
Formación de Matthew Blischak.
| Case Western Reserve University | Undergraduate Degree |
| American University Washington College of Law | Graduate Degree |
| The Johns Hopkins University | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Graduate Degree | 2 |
| Chief Executive Officer | 1 |
| President | 1 |
Sectorial
| Consumer Services | 4 |
| Health Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Empresas privadas | 1 |
|---|---|
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Matthew Blischak
- Experiencia
